![Richard A. F. Dixon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard A. F. Dixon
Oprichter bij 7 Hills Pharma LLC
Actieve functies van Richard A. F. Dixon
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
7 Hills Pharma LLC
![]() 7 Hills Pharma LLC Pharmaceuticals: MajorHealth Technology 7 Hills Pharma LLC is a clinical-stage pharmaceutical company based in Houston, TX. The private company is developing first-in-concept integrin activators to augment immunotherapies for the treatment of drug-resistant solid tumors and infectious diseases. The lead compound, 7HP349, is an oral VLA-4/LFA-1 allosteric activator that will be in phase I testing for PD-1 refractory solid tumors and geriatric influenza. The company's compounds are expected to augment antigen presentation and immune priming to facilitate a productive immune response against a variety of antigens. 7 Hills Pharma is managed by an experienced group of pharmaceutical executives, including Richard A. F. Dixon, Upendra K. Marathi, Kala Marathi, Peter Vanderslice, and Darren Woodside. Upendra K. Marathi has been the CEO since incorporation. | Oprichter | - | - |
Corporate Officer/Principal | - | - |
Loopbaan van Richard A. F. Dixon
Eerdere bekende functies van Richard A. F. Dixon
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Encysive Pharmaceuticals, Inc.
![]() Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Hoofd Techniek/Wetenschap/O&O | 01-07-1990 | 29-04-2011 |
Merck Sharp & Dohme Research Laboratories | Directeur/Bestuurslid | 01-01-1988 | 01-01-1990 |
Corporate Officer/Principal | 01-01-1988 | 01-01-1990 |
Opleiding van Richard A. F. Dixon
Texas A&M University | Undergraduate Degree |
Baylor College of Medicine | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 6 |
Operationeel
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Encysive Pharmaceuticals, Inc.
![]() Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Health Technology |
Merck Sharp & Dohme Research Laboratories | |
7 Hills Pharma LLC
![]() 7 Hills Pharma LLC Pharmaceuticals: MajorHealth Technology 7 Hills Pharma LLC is a clinical-stage pharmaceutical company based in Houston, TX. The private company is developing first-in-concept integrin activators to augment immunotherapies for the treatment of drug-resistant solid tumors and infectious diseases. The lead compound, 7HP349, is an oral VLA-4/LFA-1 allosteric activator that will be in phase I testing for PD-1 refractory solid tumors and geriatric influenza. The company's compounds are expected to augment antigen presentation and immune priming to facilitate a productive immune response against a variety of antigens. 7 Hills Pharma is managed by an experienced group of pharmaceutical executives, including Richard A. F. Dixon, Upendra K. Marathi, Kala Marathi, Peter Vanderslice, and Darren Woodside. Upendra K. Marathi has been the CEO since incorporation. | Health Technology |
- Beurs
- Insiders
- Richard A. F. Dixon
- Ervaring